Skip to content

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
ITG
Integer HoldingsITGR
$4.4B-19.6%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s enterprise value?
Pulse Biosciences, Inc. (PLSE) reported enterprise value of $1.41B in Q1 2026.
How has Pulse Biosciences, Inc.'s enterprise value changed year-over-year?
Pulse Biosciences, Inc.'s enterprise value increased by 48.1% year-over-year, from $950.05M to $1.41B.
What is the long-term trend for Pulse Biosciences, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s enterprise value has grown at a 6.7% compound annual growth rate (CAGR), from $620.97M to $857.24M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.